Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
| Author/creator | United States |
| Format | Electronic |
| Publication | Washington : U.S. Government Publishing Office, 2016. |
| Description | 1 online resource (v, 146 pages) |
| Supplemental Content | https://purl.fdlp.gov/GPO/gpo66684 |
| Subjects |
| General note | Title from title screen (viewed on Mar. 31, 2016). |
| General note | Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. |
| General note | "Serial No. 113-132." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references. |
| Issued in other form | Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining concerns regarding FDA's proposed changes to generic drug labeling |
| Issued in other form | Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining concerns regarding FDA's proposed changes to generic drug labeling |
| Genre/form | Legislative hearings. |
| Technical rpt number | Serial no. 113-132 (United States. Congress. House. Committee on Energy and Commerce) |
| GPO item number | 1019-C-01 (online) |
| Govt. docs number | Y 4.C 73/8:113-132 |